Dbv technologies reports third quarter 2024 financial results

ChÂtillon, france, november 6, 2024 dbv technologies reports third quarter 2024 financial results dbv closes q3 2024 with a cash balance of $46.4 million; cash runway into q1 2025 dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt – cusip: 23306j200), a clinical-stage biopharmaceutical company, today reported financial results for the third quarter of 2024. the quarterly and nine months financial statements were approved by the board of directors on november 6, 2024.
DBVT Ratings Summary
DBVT Quant Ranking